BUZZ - International Paper stock rises, says it is evaluating a potential sale of its Europe, Middle East, and Africa (EMEA) business
路透社2026/10/15 17:22Update
October 15 - ** International Paper (IP.N) shares rose as much as 8.5% in afternoon trading to $34.62 per share
** If the gains hold, the stock is set for its best single-day performance in nearly three months
** The company said it is evaluating takeover bids for its Europe, Middle East, and Africa packaging business and is in talks with potential bidders as it pursues its plan to split into two publicly listed companies
** The Financial Times reported earlier in the day that private equity firms Lone Star and Atlas Holdings are considering a multi-billion dollar offer for International Paper's (link) European packaging business, which is valued at under $6 billion
** The company announced in January this year that it would streamline operations and boost production efficiency in North America by spinning off its European packaging business and link splitting into two listed companies
** In 2024, IP completed its $7.2 billion acquisition of London-based rival DS Smith
** As of the previous trading day's close, the stock was down 19% year-to-date
(To facilitate non-native English speakers, Reuters has automatically translated this report into several other languages. As automated translation may contain inaccuracies or lack necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it only for reader convenience. Reuters accepts no responsibility for any loss or damage arising from the use of this automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Preview: Travelers' revenue is expected to decline slightly this quarter
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.